Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSulNOx Regulatory News (SNOX.PL)

Share Price Information for SulNOx (SNOX.PL)

Share Price is delayed by 15 minutes
Get Live Data
52.50    0.00 (0.00%)
Bid:
50.00
Ask:
55.00
Spread: 5.00 (10.00%)
Market Cap: £75.89m
SNOX.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday SulNOx Share Chart

Director's Share Purchase

28 Sep 2023 07:00

RNS Number : 9054N
SulNOx Group PLC
28 September 2023
 

28 September 2023

SulNOx Group Plc (the "Company" or "SulNOx")

Director's Share Purchase

 

 

(Aquis Stock Exchange: SNOX)

The Company is pleased to announce that Lord Nicholas Fairfax, a non-executive director of the Company, has purchased 28,000 ordinary shares of 2 pence each ("Ordinary Shares"). Following the purchase, Lord Fairfax holds 239,757 Ordinary Shares, equivalent to 0.22% of the issued Ordinary Shares.

- Ends -

 

For further information please contact:

 

 

SulNOx Group plc Steven Cowin, CFO

 

steven.cowin@sulnoxgroup.com

 

 

Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale

 

Tel: 020 3328 5656

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Lord Nicholas Fairfax

 

 

2

Reason for notification

 

a)

Position / status

Director - Non-Executive 

 

b)

Initial notification/Amendment

Initial Notification

 

3

Details of the issueremission allowancmarkeparticipant, auction platform, auctioneer or auction monitor

 

a)

Name

SulNOx Group plc

 

b)

LEI

21380011EU95E93AQN91

 

4

Details of thtransaction(s): section tbrepeatefor (ieactype of instrument(ii) each type of transaction(iii) eacdate; an(iv) eacplacwhertransactionhave beeconducted

 

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2 pence each

 

ISIN: GB00BJVQQP66

 

 

Nature of the transaction

Purchase of shares on the market

 

 

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

20.44p

 

28,000

 

 

d)

Aggregated information

Aggregated volume

Price

N/A

 

 

e)

Date of the transaction

27 September 2023

 

f)

Place of the transaction

Aquis Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXUBOBROVUKUAR
Date   Source Headline
3rd Jun 202612:00 pmRNSGrant of Share Options
1st Jun 20267:00 amRNS-RDistribution agreement with France's DLBC
26th May 20267:00 amRNS-RSkyzone deal marks entry into Pakistan market
11th May 20267:00 amRNSPPS Deal Expands India & Sri Lanka Distribution
7th May 20267:00 amRNSAlgeria patent granted for fuel oil reclamation
5th May 20267:00 amRNSDistribution agreement with India's Aditya
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNS-RInvestor Webinar via Turner Pope Investments
29th Apr 20267:00 amRNSTrading Update: Record revenues in Q4 & Full Year
24th Apr 20267:00 amRNSIssue of Shares to EPS Ventures & Consultant
22nd Apr 20267:00 amRNSHong Kong patent granted for fuel oil reclamation
15th Apr 20267:00 amRNSSubscription for Shares to raise £2m
25th Mar 20267:00 amRNSPatents for Chile, Peru, Israel
16th Mar 20267:00 amRNS-RIndependent testing demonstrates biofuel benefits
16th Mar 20267:00 amRNS-RIndependent testing demonstrates biofuel benefits
5th Mar 20267:00 amRNSPan Marine distribution and fleet adoption
25th Feb 20267:00 amRNS-RDistribution agreement with Fluid Intelligence Oy
10th Feb 20267:00 amRNS-RDistribution agreement with Motor Plus, Panama
2nd Feb 20265:00 pmRNSQ3 Trading Update: Year-to-date sales up 161%
30th Jan 20265:00 pmRNSTotal Voting Rights
27th Jan 20267:00 amRNSSouth Korea patent strengthens Asia presence
23rd Jan 20267:00 amRNSIssue of Shares to EPS Ventures Pte Ltd.
19th Jan 20267:00 amRNSSth Africa patent expands fuel oil reclamation IP
16th Jan 20267:00 amRNSAsia presence strengthened with Vietnam patent
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSFinancial Results for the 6 Months to 30 Sep 2025
29th Dec 20257:00 amRNSFinancial Results for the 6 Months to 30 Sep 2025
22nd Dec 20257:00 amRNSExercise of Warrants
22nd Dec 20257:00 amRNSExercise of Warrants
16th Dec 20257:00 amRNSAustralia patent granted
15th Dec 202512:00 pmRNSGrant of Share Options
4th Dec 20257:00 amRNSIssue of Warrants
24th Nov 20257:00 amRNSMajor distribution agreement with Drew Marine
11th Nov 20257:00 amRNS-RSulnox at Aquis Showcase Investor Conference
6th Nov 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
3rd Nov 20257:00 amRNSSpring Marine fleet-wide adoption on 28 vessels
31st Oct 20255:00 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSQ2 Trading Update: Another Record Quarter
23rd Oct 20257:30 amRNSIssue of Shares to EPS Ventures Pte Ltd.
23rd Oct 20257:00 amRNSEurope patent granted for fuel reclamation
16th Oct 20257:00 amRNS-RSulnox selected for ADIPEC 2025
14th Oct 20252:30 pmRNS-RSulnox to present at Global Markets Forum New York
30th Sep 20255:00 pmRNSTotal Voting Rights
26th Sep 20255:32 pmRNSResult of AGM
22nd Sep 20259:00 amRNSIssue of Shares to Consultant
8th Sep 20257:00 amRNS-RSulnox Expands UK Marine Market Access with C-Quip
5th Sep 20256:00 pmRNSAnnual Financial Report
5th Sep 20251:00 pmRNSFinal Results & Trading Update
3rd Sep 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.